285. Fanconi anemia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 62 / Drugs : 93 - (DrugBank : 30) / Drug target genes : 30 - Drug target pathways : 144
Fanconi anemia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
285 | Fanconi anemia | - |
60 | Aplastic anemia | 24.679 |
65 | Primary immunodeficiency | 21.991 |
46 | Malignant rheumatoid arthritis | 21.396 |
49 | Systemic lupus erythematosus | 18.716 |
13 | Multiple sclerosis/Neuromyelitis optica | 18.097 |
284 | Diamond-Blackfan anemia | 16.691 |
96 | Crohn disease | 15.488 |
51 | Scleroderma | 14.513 |
19 | Lysosomal storage disease | 13.952 |
53 | Sjogren syndrome | 13.156 |
283 | Acquired pure red cell aplasia | 12.341 |
164 | Oculocutaneous albinism | 12.047 |
62 | Paroxysmal nocturnal hemoglobinuria | 11.511 |
45 | Eosinophilic granulomatosis with Polyangiitis | 10.954 |
41 | Giant cell arteritis | 10.909 |
55 | Relapsing polychondritis | 10.419 |
11 | Myasthenia gravis | 10.000 |
85 | Idiopathic interstitial pneumonia | 9.740 |
97 | Ulcerative colitis | 9.369 |
42 | Polyarteritis nodosa | 9.317 |
50 | Dermatomyositis | 8.711 |
93 | Primary biliary cholangitis | 8.370 |
2 | Amyotrophic lateral sclerosis | 8.154 |
95 | Autoimmune hepatitis | 8.067 |
286 | Hereditary sideroblastic anemia | 8.000 |
35 | Pemphigus | 7.517 |
64 | Thrombotic thrombocytopenic purpura | 7.500 |
162 | Pemphigoid | 7.418 |
222 | Primary nephrotic syndrome | 7.203 |
40 | Takayasu arteritis | 7.099 |
61 | Autoimmune hemolytic anemia | 7.099 |
28 | Systemic amyloidosis | 7.084 |
38 | Stevens-Johnson syndrome | 6.480 |
107 | Juvenile idiopathic arthritis | 6.462 |
39 | Toxic epidermal necrolysis | 6.400 |
20 | Adrenoleukodystrophy | 6.364 |
228 | Bronchiolitis obliterans | 6.356 |
326 | Osteopetrosis | 6.244 |
56 | Behcet disease | 6.162 |
234 | Peroxisomal disease (except Adrenoleukodystrophy) | 6.044 |
151 | Rasmussen encephalitis | 6.000 |
63 | Idiopathic thrombocytopenic purpura | 5.736 |
299 | Cystic fibrosis | 5.700 |
36 | Epidermolysis bullosa | 5.597 |
113 | Muscular dystrophy | 5.332 |
224 | Purpura nephritis | 5.262 |
6 | Parkinson disease | 5.260 |
66 | IgA nephropathy | 5.238 |
302 | Leber hereditary optic neuropathy | 5.000 |
160 | Congenital ichthyosis | 4.741 |
226 | Interstitial cystitis with Hunners ulcer | 4.375 |
44 | Wegener granulomatosis | 4.368 |
43 | Microscopic polyangiitis | 4.317 |
26 | HTLV-1-associated myelopathy | 4.192 |
84 | Sarcoidosis | 4.146 |
300 | IgG4-related disease | 4.138 |
269 | Pyogenic arthritis | 4.138 |
158 | Tuberous sclerosis | 3.474 |
271 | Ankylosing spondylitis | 3.278 |
86 | Pulmonary arterial hypertension | 3.267 |
227 | Osler disease | 3.267 |
274 | Osteogenesis Imperfecta | 3.257 |
331 | Idiopathic multicentric castleman disease | 2.845 |
270 | Chronic recurrent multifocal osteomyelitis | 2.844 |
83 | Addison disease | 2.844 |
94 | Primary sclerosing cholangitis | 2.716 |
77 | Growth hormone secreting pituitary adenoma | 2.000 |
16 | Crow-Fukase syndrome | 1.920 |
58 | Hypertrophic cardiomyopathy | 1.800 |
90 | Retinitis pigmentosa | 1.788 |
81 | Congenital adrenal hyperplasia | 1.689 |
76 | Pituitary gonadotropin secretion hyperthyroidism | 1.650 |
256 | Muscle glycogenosis | 1.505 |
25 | Progressive multifocal leukoencephalopathy | 1.457 |
229 | Autoimmune pulmonary alveolar proteinosis | 1.378 |
172 | Hypophosphatasia | 1.378 |
127 | Frontotemporal lobar degeneration | 1.354 |
34 | Neurofibromatosis | 1.073 |
15 | Inclusion body myositis | 1.036 |
52 | Mixed connective tissue disease | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |
137 | Focal cortical dysplasia | 1.000 |
192 | Cockayne syndrome | 1.000 |
277 | Lymphangiomatosis | 1.000 |
281 | Klippel-Trenaunay-Weber syndrome | 1.000 |